Feedback
AUROPHARMA 
Reputation: 642,681 • Jun 26, 2023 12:36 PM
Stocks in news: TCS, HDFC Life, Shree Cement, Aurobindo Pharma, Bank of Maharashtra
The European Medicines Agencys (EMA) Committee has accepted Aurobindo Pharma subsidiary CuraTeQ Biologics' request to withdraw the applications for marketing authorization of ZEFYLTI (a filgrastim biosimilar) and DYRUPEG (a pegfilgrastim biosimilar).
The Economic Times
Vote
Comment
2 Shares
NSE:AUROPHARMA price when posted: 699.15